{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:22:00Z","timestamp":1778617320660,"version":"3.51.4"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015872","name":"Universit\u00e9 de Lille","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004795","name":"Institut Universitaire de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004562","name":"Minist\u00e8re de l&apos;Enseignement sup\u00e9rieur et de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["PCT\/IB2024\/00093"],"award-info":[{"award-number":["PCT\/IB2024\/00093"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.it.2025.08.006","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T03:45:04Z","timestamp":1758599104000},"page":"220-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nonclassical HLA and pseudogenes in maternal\u2013fetal tolerance and cancer"],"prefix":"10.1016","volume":"47","author":[{"given":"Marie","family":"Duhamel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tristan","family":"Cardon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Ziane-Chaouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4318-0817","authenticated-orcid":false,"given":"Michel","family":"Salzet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2025.08.006_bb0005","article-title":"Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates","author":"Medawar","year":"1953","journal-title":"Symp. Soc. Exp. Biol."},{"key":"10.1016\/j.it.2025.08.006_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/jhg.2008.5","article-title":"The HLA genomic loci map: expression, interaction, diversity and disease","volume":"54","author":"Shiina","year":"2009","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.it.2025.08.006_bb0015","series-title":"Immunobiology: The Immune System in Health and Disease","article-title":"The major histocompatibility complex and its functions","author":"Janeway","year":"2001"},{"key":"10.1016\/j.it.2025.08.006_bb0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-1759(02)00199-0","article-title":"Tetrameric complexes of HLA-E, HLA-F, and HLA-G","volume":"268","author":"Allan","year":"2002","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.it.2025.08.006_bb0025","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.12688\/f1000research.124416.1","article-title":"HLA class I and discoveries of the HLA-K (pseudogene) related to disease severity and progression in patients with spondyloarthritis in Dr. Soetomo General Hospital, a tertiary health care center in Surabaya, Indonesia","volume":"11","author":"Nisa\u2019","year":"2022","journal-title":"F1000Research"},{"key":"10.1016\/j.it.2025.08.006_bb0030","first-page":"247","article-title":"Origin and evolution of HLA class I pseudogenes","volume":"12","author":"Hughes","year":"1995","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.it.2025.08.006_bb0035","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.4049\/jimmunol.149.6.1934","article-title":"The HLA class I gene family includes at least six genes and twelve pseudogenes and gene fragments","volume":"149","author":"Geraghty","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nri.2017.143","article-title":"HLA variation and disease","volume":"18","author":"Dendrou","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0045","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fonc.2020.00156","article-title":"Endometrial cancer immune escape mechanisms: let us learn from the fetal\u2013maternal interface","volume":"10","author":"Bruno","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.it.2025.08.006_bb0050","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat6114","article-title":"Immune responses at the maternal-fetal interface","volume":"4","author":"Ander","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri1570","article-title":"MHC class I molecules and KIRs in human history, health and survival","volume":"5","author":"Parham","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.placenta.2010.10.010","article-title":"Genome-wide expression profile of first trimester villous and extravillous human trophoblast cells","volume":"32","author":"Apps","year":"2011","journal-title":"Placenta"},{"key":"10.1016\/j.it.2025.08.006_bb0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00251-004-0673-2","article-title":"HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms","volume":"56","author":"Hviid","year":"2004","journal-title":"Immunogenetics"},{"key":"10.1016\/j.it.2025.08.006_bb0070","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1073\/pnas.0337539100","article-title":"HLA-G gene repression is reversed by demethylation","volume":"100","author":"Moreau","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.08.006_bb0075","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.08.006_bb0080","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.4049\/jimmunol.1000078","article-title":"HLA-F complex without peptide binds to MHC class I protein in the open conformer form","volume":"184","author":"Goodridge","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0085","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3389\/fimmu.2017.00832","article-title":"Human leukocyte antigen (HLA) and immune regulation: how do classical and non-classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections?","volume":"8","author":"Crux","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.tibs.2020.10.003","article-title":"Shedding light on the ghost proteome","volume":"46","author":"Cardon","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.it.2025.08.006_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.914593","article-title":"Non-coding RNAs and oral cancer: small molecules with big functions","volume":"12","author":"Erfanparast","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.it.2025.08.006_bb0100","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jgyn.2014.06.008","article-title":"Trophoblast: conductor of the maternal immune tolerance [in French]","volume":"43","author":"Mesdag","year":"2014","journal-title":"J. Gynecol. Obstet. Biol. Reprod. (Paris)"},{"key":"10.1016\/j.it.2025.08.006_bb0105","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jgyn.2012.07.001","article-title":"Immunological aspect of pregnancy [in French]","volume":"41","author":"Hanssens","year":"2012","journal-title":"J. Gynecol. Obstet. Biol. Reprod. (Paris)"},{"key":"10.1016\/j.it.2025.08.006_bb0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jgyn.2012.10.007","article-title":"Immunological analogies between ovarian cancer and pregnancy [in French]","volume":"42","author":"Hanssen","year":"2013","journal-title":"J. Gynecol. Obstet. Biol. Reprod. (Paris)"},{"key":"10.1016\/j.it.2025.08.006_bb0115","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1172\/JCI68107","article-title":"Uterine NK cells: active regulators at the maternal-fetal interface","volume":"124","author":"Moffett","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2025.08.006_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.979800","article-title":"The antigen processing-associated transporter gene polymorphism: role on gene and protein expression in HPV-infected pre-cancerous cervical lesion","volume":"12","author":"Medeiros","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.it.2025.08.006_bb0125","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.trecan.2021.01.004","article-title":"HLA-G\/LILRBs: a cancer immunotherapy challenge","volume":"7","author":"Carosella","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.it.2025.08.006_bb0130","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.1016\/j.ajog.2019.11.479","article-title":"463: Placental expression of HLA-G, C, E, and F in preterm severe preeclampsia and preterm labor [abstract]","volume":"222","author":"Hackmon","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.it.2025.08.006_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.884275","article-title":"Human leukocyte antigens in pregnancy and preeclampsia","volume":"13","author":"Aisagbonhi","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.it.2025.08.006_bb0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.humimm.2020.03.005","article-title":"Naming HLA diversity: a review of HLA nomenclature","volume":"82","author":"Hurley","year":"2021","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0145","doi-asserted-by":"crossref","first-page":"10139","DOI":"10.1158\/0008-5472.CAN-05-0097","article-title":"HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?","volume":"65","author":"Rouas-Freiss","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.it.2025.08.006_bb0150","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1073\/pnas.1431057100","article-title":"Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G","volume":"100","author":"Shiroishi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.08.006_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.592010","article-title":"Roles of HLA-G in the maternal-fetal immune microenvironment","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0160","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fimmu.2012.00258","article-title":"KIR2DL4 (CD158d): an activation receptor for HLA-G","volume":"3","author":"Rajagopalan","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2020.103176","article-title":"Possible roles of HLA-G regulating immune cells in pregnancy and endometrial diseases via KIR2DL4","volume":"142","author":"Bai","year":"2020","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0170","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M","article-title":"HLA-E is expressed on trophoblast and interacts with CD94\/NKG2 receptors on decidual NK cells","volume":"30","author":"King","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0175","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1073\/pnas.1507977112","article-title":"Human HLA-G+ extravillous trophoblasts: immune-activating cells that interact with decidual leukocytes","volume":"112","author":"Tilburgs","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.08.006_bb0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jri.2005.10.004","article-title":"The involvement of HLA-E and-F in pregnancy","volume":"69","author":"Ishitani","year":"2006","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0185","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12643","article-title":"Definitive class I human leukocyte antigen expression in gestational placentation: HLA-F, HLA-E, HLA-C, and HLA-G in extravillous trophoblast invasion on placentation, pregnancy, and parturition","volume":"77","author":"Hackmon","year":"2017","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163297","article-title":"HLA-F and MHC-I open conformers bind natural killer cell Ig-like receptor KIR3DS1","volume":"11","author":"Burian","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.it.2025.08.006_bb0195","doi-asserted-by":"crossref","first-page":"13312","DOI":"10.1073\/pnas.1517724112","article-title":"The HLA-G cycle provides for both NK tolerance and immunity at the maternal\u2013fetal interface","author":"Tilburgs","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.08.006_bb0200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.ai.2015.04.001","article-title":"HLA-G: an immune checkpoint molecule","volume":"127","author":"Carosella","year":"2015","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0205","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00018-022-04359-2","article-title":"The HLA-G immune checkpoint: a new immuno-stimulatory role for the \u03b11-domain-deleted isoform","volume":"79","author":"Tronik-Le Roux","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.it.2025.08.006_bb0210","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3389\/fimmu.2020.01613","article-title":"HLA-G expressing immune cells in immune mediated diseases","volume":"11","author":"Contini","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0215","doi-asserted-by":"crossref","first-page":"10656","DOI":"10.1073\/pnas.1100354108","article-title":"HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes","volume":"108","author":"Gooden","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.08.006_bb0220","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-3-030-17864-2_2","article-title":"MHC\/HLA class I loss in cancer cells","volume":"1151","author":"Garrido","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.it.2025.08.006_bb0225","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.191.6.961","article-title":"Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer","volume":"191","author":"Koopman","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2025.08.006_bb0230","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005345","article-title":"Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice","volume":"10","author":"K\u00fc\u00e7\u00fckk\u00f6se","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.it.2025.08.006_bb0235","article-title":"Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies","volume":"15","author":"Melero","year":"2023","journal-title":"EMBO Mole. Med."},{"key":"10.1016\/j.it.2025.08.006_bb0240","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.3390\/vaccines10121993","article-title":"Disruption of the NKG2A: HLA-E immune checkpoint axis to enhance NK cell activation against cancer","volume":"10","author":"Fisher","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.it.2025.08.006_bb0245","doi-asserted-by":"crossref","first-page":"501","DOI":"10.18632\/oncotarget.28610","article-title":"Strategies to disrupt NKG2A: HLA-E interactions for improved anti-cancer immunity","volume":"15","author":"Fisher","year":"2024","journal-title":"Oncotarget"},{"key":"10.1016\/j.it.2025.08.006_bb0250","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13046-025-03390-y","article-title":"Targeting the HLA-E\u2013NKG2A axis in combination with MS-275 enhances NK cell-based immunotherapy against DMG","volume":"44","author":"Deng","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.it.2025.08.006_bb0255","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/ni.3513","article-title":"Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1","volume":"17","author":"Garcia-Beltran","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0260","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.it.2017.01.009","article-title":"HLA-G: at the interface of maternal\u2013fetal tolerance","volume":"38","author":"Ferreira","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0265","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/nm.4444","article-title":"Targeting the T cell receptor \u03b2-chain constant region for immunotherapy of T cell malignancies","volume":"23","author":"Maciocia","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2025.08.006_bb0270","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00018-010-0579-0","article-title":"The role of HLA-G in immunity and hematopoiesis","volume":"68","author":"Carosella","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.it.2025.08.006_bb0275","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1073\/pnas.93.2.705","article-title":"Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum","volume":"93","author":"Bianchi","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.08.006_bb0280","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/art.11324","article-title":"The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review","volume":"48","author":"Khosrotehrani","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2025.08.006_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jri.2005.02.001","article-title":"Natural history of fetal cell microchimerism during and following murine pregnancy","volume":"66","author":"Khosrotehrani","year":"2005","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0290","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1126\/science.1164511","article-title":"Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero","volume":"322","author":"Mold","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.it.2025.08.006_bb0295","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/0891693031000067304","article-title":"Microchimerism in human health and disease","volume":"36","author":"Nelson","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.it.2025.08.006_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2005.04.019","article-title":"Pathophysiology of fetal microchimeric cells","volume":"360","author":"Artlett","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.it.2025.08.006_bb0305","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2174\/1566524023362131","article-title":"Microchimerism in health and disease","volume":"2","author":"Artlett","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.it.2025.08.006_bb0310","doi-asserted-by":"crossref","first-page":"9035","DOI":"10.1158\/0008-5472.CAN-06-4209","article-title":"Fetal microchimerism in women with breast cancer","volume":"67","author":"Gadi","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.it.2025.08.006_bb0315","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2008.07.025","article-title":"Fetal microchimerism and cancer","volume":"276","author":"Gadi","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.it.2025.08.006_bb0320","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10549-009-0548-1","article-title":"Fetal microchimerism in breast from women with and without breast cancer","volume":"121","author":"Gadi","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.it.2025.08.006_bb0325","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.4049\/jimmunol.174.11.7123","article-title":"Influence of maternal-fetal histocompatibility and MHC zygosity on maternal microchimerism","volume":"174","author":"Kaplan","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.08.006_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103664","article-title":"Feto-maternal microchimerism: memories from pregnancy","volume":"25","author":"Comitre-Mariano","year":"2022","journal-title":"Iscience"},{"key":"10.1016\/j.it.2025.08.006_bb0335","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2353\/ajpath.2009.080566","article-title":"Fetal microchimeric cells participate in tumour angiogenesis in melanomas occurring during pregnancy","volume":"174","author":"Huu","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.it.2025.08.006_bb0340","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1073\/pnas.0802736105","article-title":"Structural basis for NKG2A\/CD94 recognition of HLA-E","volume":"105","author":"Kaiser","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.08.006_bb0345","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4326495","article-title":"Recent advances in our understanding of HLA-G biology: lessons from a wide spectrum of human diseases","volume":"2016","author":"Morandi","year":"2016","journal-title":"J Immunol Res"}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490625002169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490625002169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:51:36Z","timestamp":1778615496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490625002169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1471490625002169"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2025.08.006","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonclassical HLA and pseudogenes in maternal\u2013fetal tolerance and cancer","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2025.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}